CSS Coagulation - Attachment 3 Quote Sheet Amendment 0008.xlsx

This is a Quote Sheet Amendment for Request for Quotation (RFQ) HT941026Q2004, the FY26 Lab Consolidation for Coagulation CPRR Effort issued by the Defense Health Agency (DHA) Healthcare Contracting Division - West. The solicitation seeks quotes for a cost-per-reportable-result (CPRR) contract to provide coagulation analyzer services to military treatment facilities across five geographic networks: Pacific Rim, Indo-Pacific, Continental, Central, and West. The requirement encompasses 23 specific coagulation tests including Prothrombin Time, Activated Partial Thromboplastin Time, Fibrinogen, D-Dimer, Heparin, Lupus Anticoagulant, and various Factor assays, with an estimated annual test count of 100,711 across ten clinical sites including Naval Hospitals, Army Medical Centers, and Air Force Medical Groups. The contract structure includes a base period (October 1, 2026 – September 30, 2027) and four option periods (each one fiscal year), organized into five Contract Line Item Numbers (CLINs) per period corresponding to each geographic network.

Quotes must be submitted using this Quote Sheet Amendment 0008 with pricing per reportable result for each test at each facility, and the government anticipates a 2-4 month analyzer transition period upon contract award. The quotation due date, as amended through Amendment 0008, is September 17, 2026. Offerors must acknowledge receipt of all eight amendments (0001 through 0008), agree to hold prices firm for 60 calendar days from the quote receipt date, and provide information including company name, address, CAGE code, Unique Entity ID, and authorized signatory. This is an unrestricted procurement under FAR Part 12 for commercial products, with NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing) and a 1000-employee size standard, not set-aside for small business.